FINNENCE ▪ THE WIRE FILE
THE WIRE · № 79777
Company■ Mixed
Phase 3 results posted: A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome — Hoffmann-La Roche
KINDCompany
DIRECTION■ Mixed
SOURCES1
ENTITIES3
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Roche Phase 3 results in pediatric nephrotic syndrome could inform obinutuzumab's label expansion.
Obinutuzumab data point in pediatric disease
CATALYST TO WATCH
Regulatory filing and peer review
MAIN RISK
Outcome direction not stated in text
FULL DISPATCH
Sponsor: Hoffmann-La Roche; Status: Completed; Conditions: Childhood Idiopathic Nephrotic Syndrome; Interventions: Obinutuzumab, MMF, Prednisone; Enrollment: 85 (actual); First posted: 2022-11-25; Results posted: 2026-10-14; NCT: NCT05627557
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare, XBI
Phase 3 results posted: A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa) — Ultragenyx Pharmaceutical Inc2026-10-14 12:00 UTC
Phase 3 results posted: A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa) — Ultragenyx Pharmaceutical Inc2026-10-14 12:00 UTC
→CORRELATIONshares Healthcare
WIN Expands Executive Leadership Team Following Period of Rapid Growth2026-10-14 12:57 UTC
WIN Expands Executive Leadership Team Following Period of Rapid Growth2026-10-14 12:57 UTC
→CORRELATIONshares Healthcare
FLSC IPO News - Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO2026-10-14 12:32 UTC
FLSC IPO News - Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO2026-10-14 12:32 UTC
→CORRELATIONshares Healthcare
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs2026-10-14 13:15 UTC
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs2026-10-14 13:15 UTC
→CORRELATIONshares Healthcare
Attorney Tracy Paulsen Brings Focused Experience to Growing GLP-1 Vision Loss and NAION Litigation2026-10-14 13:17 UTC
Attorney Tracy Paulsen Brings Focused Experience to Growing GLP-1 Vision Loss and NAION Litigation2026-10-14 13:17 UTC
→CORRELATIONshares Healthcare
Proposed 2027 Medicare Cuts Threaten Seniors' Access to Care Amid Growing Physician Shortage2026-10-14 14:28 UTC
Proposed 2027 Medicare Cuts Threaten Seniors' Access to Care Amid Growing Physician Shortage2026-10-14 14:28 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.